AstraZeneca

MedImmune, is a company that produces Synagis, a drug for the prevention of respiratory infections in infants, which accounted for US$ 1.06 billion of its US$ 1.2 billion in revenue for 2005, and FluMist, a nasal spray influenza vaccine introduced in 2004. MedImmune has over 120 drugs in development for conditions including lupus, COPD, asthma, and many types of cancer.

MedImmune

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca has entered into a collaboration agreement with Massachusetts General Hospital (MGH), leveraging robust data and clinical best practices to create digital health solutions that address today's most urgent healthcare challenges. Catalyzed by the COVID-19 pandemic and a shared mission to improve care for patients with chronic illness, this novel partnership is focused on creating and clinically validating patient-centric digital health solutions and

AstraZeneca Announces Collaboration with Massachusetts General Hospital to Accelerate Digital Health Solutions

People under the age of thirty might soon be advised not to take the AstraZeneca PLC (LON:AZN)/Oxford University Covid-19 vaccines, according to reports today. UK regulators, the Medicines and Healthcare products Regulatory Agency (MHRA) and the Joint Committee on Vaccination and Immunisation (JCVI), are said to be considering the change in advice ‘very urgently', said the stories.

AstraZeneca vaccine might be restricted to over-30s due to blood clot concern

Over 150,000 people in Thailand have received the AstraZeneca vaccine and the percentage of people with side effects is "very low," said Anutin Charnvirakul.

AstraZeneca Covid vaccine will be Thailand's 'principal' shot, says health minister

Johnson & Johnson

Emergent BioSolutions

Johnson & Johnson has been put in charge of COVID-19 vaccine production at a Baltimore plant where 15 million doses were ruined several weeks ago. What Happened: The U.S. Department of Health and Human Services put Johnson & Johnson (NYSE: JNJ) in charge of the Emergent BioSolutions Inc (NYSE: EBS) plant in Baltimore.

US Puts Johnson & Johnson In Charge Of Troubled Vaccine Plant In Baltimore, Removes AstraZeneca

One reason is medical and the other is financial.

Here's Why Investors Shouldn't Worry About AstraZeneca's European Woes

The European Medicines Agency has said that a link between blood clots and the vaccine is "not proven, but is possible."

U.K. Regulator Recommends Continued Use Of AstraZeneca Vaccine Despite 7 Deaths Linked To Blood Clots

How it works, authorizations, and supply deals.

What Investors Need to Know About the AstraZeneca Vaccine

Here's how the initial and follow-up reports compare.

Why Did the U.S. Question AstraZeneca's Trial Data?

Another vaccine from the company's recent past may hint at what's next.

Should Investors Be Surprised by AstraZeneca's Vaccine Struggles?

The regulator noted that no such clotting incidents were observed among people who received the Pfizer-BioNTech vaccine.

U.K. Reports 30 Cases Of Rare Blood Clots Linked To AstraZeneca Vaccine, Insists Benefits Outweigh Any Risks

AstraZeneca PLC's COVID-19 vaccine, which has been plagued by problems with its rollout, may not even be needed in the U.S., Dr. Anthony Fauci told Reuters.

Fauci says U.S. may not even need AstraZeneca's COVID-19 vaccine: report

The European Union has asked India to allow it to buy 10 million doses of AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine from Serum Institute of India, a government official told Reuters. What Happened: “The E.U.

EU Turns To India To Fill AstraZeneca Vaccine Supply Gap: Reuters

The vaccine supply debate has distracted attention from strong growth at the company. I see the vaccine arguments as a sideshow. The company should make some money from the vaccines, but more importantly, its core businesses are in strong growth mode.

AstraZeneca: No Longer Overpriced

Hello, Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

Why AstraZeneca's vaccine will be too late for the US

They all have one thing in common: Efficacy beats the bar set by the FDA.

How Does the AstraZeneca Vaccine Measure Up to Rivals?

There's a lot more to AstraZeneca than poorly presented vaccine data.

Forget the Vaccine Problems, AstraZeneca Stock Can Still Make You Rich

The big drugmaker already has a major U.S. supply deal locked up if its vaccine obtains authorization.

Can AstraZeneca Win in the U.S. COVID Vaccine Market After Its Efficacy Results Fiasco?

iBio

Moderna

Novavax

Ocugen, Inc.

VanEck Vectors Pharmaceutical ETF

Sorrento Therapeutics Inc

Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared first on InvestorPlace.

7 Pharmaceutical Stocks That Could Get a Covid Hangover

There are signs that Europe's diverging — and changing — usage rules when it comes to AstraZeneca's Covid vaccine are sowing further confusion among citizens.

'Everyone here is confused': Europe's see-sawing over AstraZeneca's vaccine is stoking doubts

NEW YORK, March 31, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of AstraZeneca plc (NASDAQ: AZN) resulting from allegations that AstraZeneca may have issued materially misleading business information to the investing public. SO WHAT: If you purchased AstraZeneca securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

AZN BREAKING NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca plc Investors to Inquire About Class Action Investigation - AZN

Dr. Ashish Jha, a top US public-health expert, earlier this month laid out what he thought was an unpopular opinion. Shortly after AstraZeneca announced that its coronavirus vaccine was found to be safe and effective in a 32,000-volunteer US trial, Jha argued that the US should donate its supply of the shot to other countries, rather than reserve it for use domestically.

AstraZeneca's COVID-19 shot will come too late for the US

A U.S. government agency called out the drugmaker after it announced solid interim efficacy results.

How AstraZeneca Flubbed Its Better-Than-Expected COVID Vaccine Update

Germany has suspended use of the Covid vaccine created by AstraZeneca and the University of Oxford in the under-60s, dealing another blow to the drugmaker.

Germany suspends use of AstraZeneca's Covid shot for the under-60s, dealing another blow to drugmaker

Germany has suspended the use of the AstraZeneca COVID-19 vaccine for younger citizens over concerns of blood clotting, health officials announced on Tuesday. The AstraZeneca vaccine will not be administered to those under 60, unless they are in a high-risk category and agree to take the vaccine knowing the small risks of side effects.

Germany has suspended the use of the AstraZeneca vaccine for anyone under 60

Roku

AstraZeneca plc (NASDAQ: AZN) shares are trading lower by 2% after Berlin's state hospital halted the company's COVID-19 vaccination of women under the age of 55 years old. Last week, AstraZeneca issued a fresh update of its phase three trial data for the COVID-19 vaccine after a U.S. health agency earlier this week questioned the accuracy of the trial data.

News for AstraZeneca Stock (AZN)